Hervé POILVACHE - NMSK IREC and TFAR FACM - In-vitro and in-vivo study of biofilm disruption strategies for the treatment of Prosthetic Joint Infections

Bruxelles Woluwe

September 20, 2021

Monday 20 September, 5.15 pm, Auditoire central Maisin

Hervé POILVACHE

NMSK - IREC and TFAR - FACM (Cellular and Molecular Pharmacology)

In-vitro and in-vivo study of biofilm disruption strategies for the treatment of Prosthetic Joint Infections

Directors: Olivier Cornu (NMSK - IREC) et Françoise Van Bambeke (TFAR - FACM)

Related publications:

  • Poilvache, H., et al. (2020). "Synergistic Effects of Pulsed Lavage and Antimicrobial Therapy Against Staphylococcus aureus Biofilms in an in-vitro Model." Front Med (Lausanne) 7(527): 527
  • Poilvache, H., et al. (2021). "In Vitro Study of the Synergistic Effect of an Enzyme Cocktail and Antibiotics against Biofilms in a Prosthetic Joint Infection Model." Antimicrob Agents Chemother 65(4)

Also on Teams: https://bit.ly/3jH6wM2 

Info: francoise.vanbambeke@uclouvain.be